Gene expression signature predicting prostate cancer progression

被引：0
|
作者：
Wu, C-L
Mu, X-J
McDougal, W. S.
Erlander, M.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] AviaraDx Inc, Carlsbad, CA USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
870
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [31] TMPRSS2:ERG gene fusion expression and prostate cancer progression
    Nesi, Gabriella
    Bonaccorsi, Lorella
    Paglierani, Milena
    Krausz, Csilla
    Masieri, Lorenzo
    Serni, Sergio
    Proietti-Pannunzi, Laura
    Carim, Marco
    Forti, Gianni
    Baldi, Elisabetta
    Luzzatto, Lucio
    VIRCHOWS ARCHIV, 2007, 451 (02) : 124 - 124
  • [32] The expression of drug resistance gene products during the progression of human prostate cancer
    Sullivan, GF
    Amenta, PS
    Villanueva, JD
    Alvarez, CJ
    Yang, JM
    Hait, WN
    CLINICAL CANCER RESEARCH, 1998, 4 (06) : 1393 - 1403
  • [33] EXPRESSION OF THE TMPRSS2:ERG FUSION GENE AND PROSTATE CANCER PROGRESSION
    Nesi, Gabriella
    Bonaccorsi, Lorella
    Paglierani, Milena
    Krausz, Csilla
    Carini, Marco
    Fang, Yuqiang
    Jhanwar, Suresh C.
    Forti, Gianni
    Baldi, Elisabetta
    Luzzatto, Lucio
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3420 - 3421
  • [34] Androgen deprivation modulates gene expression profile along prostate cancer progression
    Volante, Marco
    Tota, Daniele
    Giorcelli, Jessica
    Bollito, Enrico
    Napoli, Francesca
    Vatrano, Simona
    Buttigliero, Consuelo
    Molinaro, Luca
    Gontero, Paolo
    Porpiglia, Francesco
    Tucci, Marcello
    Papotti, Mauro
    Berruti, Alfredo
    Rapa, Ida
    HUMAN PATHOLOGY, 2016, 56 : 81 - 88
  • [35] Changes in gene expression of stromal and epithelial cells during prostate cancer progression
    Babic, Milos
    Imler, Elliot
    Shepard, Peter
    Yeakley, Joanne
    Nagle, Raymond
    Seligmann, Bruce
    CANCER RESEARCH, 2017, 77
  • [36] Gene Expression Signature for Neuroendocrine Prostate Cancer Identifies Additional Markers of Neuroendocrine Differentiation
    Tsai, H.
    Tan, H-L
    Hicks, J.
    Vessela, R.
    Luo, J.
    Lotan, T. L.
    LABORATORY INVESTIGATION, 2014, 94 : 265A - 265A
  • [37] Gene Expression Signature for Neuroendocrine Prostate Cancer Identifies Additional Markers of Neuroendocrine Differentiation
    Tsai, H.
    Tan, H-L
    Hicks, J.
    Vessela, R.
    Luo, J.
    Lotan, T. L.
    MODERN PATHOLOGY, 2014, 27 : 265A - 265A
  • [38] Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer
    Kameda, Tomohiro
    Sugihara, Toru
    Obinata, Daisuke
    Oshima, Masashi
    Yamada, Yuta
    Kimura, Naoki
    Takayama, Kenichi
    Inoue, Satoshi
    Takahashi, Satoru
    Fujimura, Tetsuya
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Anoikis and Mitophagy-Related Gene Signature for Predicting the Survival and Tumor Cell Progression in Colon Cancer
    Shen, Jian
    Li, Minzhe
    CRITICAL REVIEWS IN IMMUNOLOGY, 2024, 45 (01)
  • [40] Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
    Bianco-Miotto, Tina
    Chiam, Karen
    Buchanan, Grant
    Jindal, Shalini
    Day, Tanya K.
    Thomas, Mervyn
    Pickering, Marie A.
    O'Loughlin, Melissa A.
    Ryan, Natalie K.
    Raymond, Wendy A.
    Horvath, Lisa G.
    Kench, James G.
    Stricker, Phillip D.
    Marshall, Villis R.
    Sutherland, Robert L.
    Henshall, Susan M.
    Gerald, William L.
    Scher, Howard I.
    Risbridger, Gail P.
    Clements, Judith A.
    Butler, Lisa M.
    Tilley, Wayne D.
    Horsfall, David J.
    Ricciardelli, Carmela
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) : 2611 - 2622
12345